NO20024960L - Polyamidnukleinsyrederivater, midler og fremgangsmÕter for fremstilling av disse - Google Patents

Polyamidnukleinsyrederivater, midler og fremgangsmÕter for fremstilling av disse

Info

Publication number
NO20024960L
NO20024960L NO20024960A NO20024960A NO20024960L NO 20024960 L NO20024960 L NO 20024960L NO 20024960 A NO20024960 A NO 20024960A NO 20024960 A NO20024960 A NO 20024960A NO 20024960 L NO20024960 L NO 20024960L
Authority
NO
Norway
Prior art keywords
agents
processes
preparation
nucleic acid
acid derivatives
Prior art date
Application number
NO20024960A
Other languages
English (en)
Other versions
NO328910B1 (no
NO20024960D0 (no
Inventor
Eugen Uhlmann
Gerhard Breipohl
David William Will
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20024960D0 publication Critical patent/NO20024960D0/no
Publication of NO20024960L publication Critical patent/NO20024960L/no
Publication of NO328910B1 publication Critical patent/NO328910B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20024960A 2000-04-18 2002-10-15 PNA-derivater, legemiddel, fremgangsmate for fremstilling samt anvendelse NO328910B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10019136A DE10019136A1 (de) 2000-04-18 2000-04-18 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
PCT/EP2001/004027 WO2001079249A2 (de) 2000-04-18 2001-04-07 Peptidnukleinsaure-derivate mit negativer ladung, mittel und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
NO20024960D0 NO20024960D0 (no) 2002-10-15
NO20024960L true NO20024960L (no) 2002-11-12
NO328910B1 NO328910B1 (no) 2010-06-14

Family

ID=7639144

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024960A NO328910B1 (no) 2000-04-18 2002-10-15 PNA-derivater, legemiddel, fremgangsmate for fremstilling samt anvendelse

Country Status (19)

Country Link
US (2) US6777544B2 (no)
EP (1) EP1282639B1 (no)
JP (1) JP5149475B2 (no)
KR (1) KR100815067B1 (no)
AR (1) AR030210A1 (no)
AT (1) ATE302212T1 (no)
AU (2) AU4653601A (no)
BR (1) BR0110111A (no)
CA (1) CA2406168C (no)
DE (2) DE10019136A1 (no)
DK (1) DK1282639T3 (no)
ES (1) ES2246318T3 (no)
IL (2) IL152287A0 (no)
MX (1) MXPA02009738A (no)
NO (1) NO328910B1 (no)
NZ (1) NZ522005A (no)
TW (1) TWI318213B (no)
WO (1) WO2001079249A2 (no)
ZA (1) ZA200208346B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019135A1 (de) * 2000-04-18 2001-10-31 Aventis Pharma Gmbh Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung
US7270954B1 (en) * 2000-06-30 2007-09-18 Iris Biotechnologies, Inc. Hybridization of target DNA with immobilized nucleic acid analogs
DE10159904A1 (de) * 2001-12-06 2003-07-03 Adnagen Ag Oligonukleotidanordnung, Verfahren zum Nukleotidnachweis sowie Vorrichtung hierfür
US7371852B2 (en) * 2003-01-22 2008-05-13 Serenex, Inc. Alkyl-linked nucleotide compositions
DE102006050091A1 (de) * 2006-10-24 2008-09-11 Ugichem Gesellschaft für Organische Chemie mbH Verfahren zur selektiven Lokalisierung von Wirkstoffen an und in Mitochondrien und entsprechende Wirkstoffe
JP2010528615A (ja) * 2007-05-31 2010-08-26 サノフィ−アベンティス ＮＡＰＥ−ＰＬＤ又はＡｂｈ４の活性を修飾する薬剤を同定するためのアッセイ方法
KR20090098710A (ko) * 2008-03-14 2009-09-17 주식회사 씨티아이바이오 세포투과성과 핵산 결합력이 좋은 펩타이드 핵산 유도체
TWI531370B (zh) * 2010-05-14 2016-05-01 可娜公司 藉由抑制ｐａｒ４天然反股轉錄本治療ｐａｒ４相關疾病
CA2998886C (en) 2015-09-16 2023-05-16 PetaOmics, Inc. Methods and compositions for genomic target enrichment and selective dna sequencing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
DE4408531A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag PNA-Synthese unter Verwendung einer gegen schwache Säuren labilen Amino-Schutzgruppe
ES2181799T3 (es) * 1994-10-06 2003-03-01 Isis Pharmaceuticals Inc Conjugados de acidos peptido nucleicos.
ATE206131T1 (de) 1995-03-13 2001-10-15 Aventis Pharma Gmbh Phosphonomonoesternnukleinsäuren, verfahren zu ihrer herstellung und ihre verwendung
DE19508923A1 (de) * 1995-03-13 1996-09-19 Hoechst Ag Phosphonomonoesternukleinsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19640974A1 (de) * 1996-10-04 1998-04-16 Bayer Ag Bausteine für DNA/PNA-Cooligomere
DE19757516A1 (de) * 1997-12-23 1999-06-24 Roche Diagnostics Gmbh Modifizierte Nukleinsäureanaloga
US6043352A (en) * 1998-08-07 2000-03-28 Isis Pharmaceuticals, Inc. 2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides

Also Published As

Publication number Publication date
DK1282639T3 (da) 2005-12-12
BR0110111A (pt) 2003-02-11
KR100815067B1 (ko) 2008-03-20
ZA200208346B (en) 2003-10-07
US20040265885A1 (en) 2004-12-30
KR20030036167A (ko) 2003-05-09
IL152287A (en) 2009-09-22
CA2406168A1 (en) 2001-10-25
MXPA02009738A (es) 2003-03-12
NO328910B1 (no) 2010-06-14
TWI318213B (en) 2009-12-11
AU2001246536B2 (en) 2007-02-15
WO2001079249A2 (de) 2001-10-25
ES2246318T3 (es) 2006-02-16
WO2001079249A3 (de) 2002-03-28
JP2004502649A (ja) 2004-01-29
NO20024960D0 (no) 2002-10-15
IL152287A0 (en) 2003-05-29
NZ522005A (en) 2004-12-24
ATE302212T1 (de) 2005-09-15
JP5149475B2 (ja) 2013-02-20
US6777544B2 (en) 2004-08-17
AU4653601A (en) 2001-10-30
EP1282639B1 (de) 2005-08-17
US20030022172A1 (en) 2003-01-30
AR030210A1 (es) 2003-08-13
US7241882B2 (en) 2007-07-10
DE50107121D1 (de) 2005-09-22
CA2406168C (en) 2012-01-24
DE10019136A1 (de) 2001-10-31
EP1282639A2 (de) 2003-02-12

Similar Documents

Publication Publication Date Title
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1112251T3 (da) Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater
NO20014013L (no) 16-halogen-epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem
NO20020687L (no) 3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
NO20021637D0 (no) Kjemiske forbindelser
NO20042084L (no) 6-hydroksyisoflavoner, derivater og legemidler som omfatter disse
NO20020374L (no) Karboksylsyreamider, medikamenter inneholdende disse forbindelser, deres anvendelse og fremstilling
NO20024959D0 (no) Polyamidnukleinsyrederivater, midler og fremgangsmåter for deres fremstilling
NO20023868L (no) Forgrenede, polymere, overflateaktive reaksjonsprodukter, samt fremgangsmåter for fremstilling og anvendelse derav
ATE309220T1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2- carbonsäurederivate
NO20024960D0 (no) Polyamidnukleinsyrederivater, midler og fremgangsmåter for fremstilling av disse
DK1627631T3 (da) Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme
NO20022626L (no) 1,2-fenylendiborsyrereagenser og komplekser
NO20016404D0 (no) Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
AU2001246536A1 (en) Polyamide nucleic acid derivatives, agents and methods for producing the same
DK1263719T3 (da) N-deacetylthiocolchin-derivater og farmaceutiske sammensætninger indeholdende disse.
NO20024105L (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
NO20030375D0 (no) N-substituerte 1-amino-1,1-dialkylkarboksylsyrederivater
NO20014393D0 (no) 1,3,4-oksadiazol-derivater og fremgangsmåte for fremstilling av disse
DK1043306T3 (da) 3-amino-3-arylpropan-1-ol-derivater, fremstilling og anvendelse af disse
NO20030317D0 (no) Kjemisk fremgangsmåte
NO20023845L (no) Pluraflaviner og derivater derav, fremgangsmåte for fremstilling av disse og deres anvendelse
DK1256583T3 (da) Pyrimidin-4-on-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
NO20021143L (no) Antikonvulsiv og anxiolytisk virkende 4-amino-1-aryl-1,5- dihydro-pyrrol-2-oner og fremgangsmåte for fremstilling av disse
DK1200446T3 (da) Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees